Altogether, our results provide the first evidence that IFNβ exerts modulatory effects on suppressing inflammatory and promoting anti-inflammatory MG, and that may subsequently lead to attenuated neuroinflammation and ameliorated brain injury in delayed tPA-treated ischemic stroke. Here, IFNB1 is linked to ischemic stroke.